Novo CEO says pills could capture 50% of weight-loss market by 2030
By Patrick Wingrove LONDON, Sept 22 - Weight-loss pills could capture as much as half of the global obesity drug market by 2030, Novo Nordisk's chief executive told Reuters on Tuesday, as the Danish drugmaker positions itself for a shift away from weekly injections.
